Gene Therapies
Most recent (9)
Article

Biosimilar Approval and Adoption Challenges

Accelerating the progress of biosimilars is key to lowering drug costs and improving patient access to potentially life-saving therapies.

Harold Carter, June 10, 22

Read More
""
Article

Uncovering Behind-the-Scenes Challenges in Bringing Gene Therapies to Market

Patients getting access to expensive gene therapies is just one of the many challenges to bringing these sometimes life-saving drugs to market.

Mary Dorholt, PharmD, June 07, 22

Read More
""
Article

Three Specialty Drug Trends to Prepare for: Biosimilars, Gene and Cell Therapies, Cancer Drugs

Biosimilars, gene and cell therapies, and cancer drugs are filling the specialty pipeline. Here are some insights for each category to help you stay informed. This topic was the focus of a breakout...

Harold Carter, April 20, 22

Read More
""
Article

How to Have a Data-Driven Discussion on Gene and Cellular Therapies

As the number of approved gene and cellular therapies grows, you can start preparing your organization now by taking the right next steps.

Mary Dorholt, PharmD, October 28, 21

Read More
""
Article

Ensuring Coverage is Key For Life Altering Gene Therapies

Access, cost can be insurmountable hurdles unless the patient’s plan has the proper strategies in place

Jackie Huntebrinker, August 19, 21

Read More
""
Article

We’re on the Verge of a Breakthrough for Gene Therapies

The first gene therapies have come to market. Hundreds more are in the drug pipeline.

Mary Dorholt, PharmD, July 08, 21

Read More
""